Social inequality in accessing cancer drugs has become a pressing issue within the legal regime of India's healthcare system. Despite advancements in medical technology and drug development, disparities persist in the availability, affordability, and accessibility of cancer medications among different socio-economic groups. This paper explores the multifaceted nature of social inequality in accessing cancer drugs within the legal framework of India. It examines the root causes of these disparities, including economic disparities, lack of healthcare infrastructure in rural areas, and regulatory barriers to drug access. Furthermore, the abstract discusses the legal and policy mechanisms aimed at addressing social inequality in drug accessibility, such as price regulation, compulsory licensing, and public health initiatives. By analyzing the intersection of social inequality and the legal regime governing cancer drug accessibility in India, this abstract aims to shed light on the challenges faced by vulnerable populations and the potential avenues for policy reform to ensure equitable access to life-saving medications.